Keywords
Dialysis
Catheter-associated bacteremia
How to Cite
Abstract
Introduction: Bacterial pericarditis is unusual, but it must be considered in the spectrum of potential complications in a patient with bacteremia associated with the central venous catheter.
Purpose: Approach a rapid recognition and treatment to avoid potentially fatal complications.
Case presentation: Female, 50 years old with diagnosis of bacterial pericarditis due to Aeromonas hydrophila in the context of hemodialysis catheter-related bacteremia that required pericardiocentesis.
Discussion and conclusion: The review of this case report allow us to recognize the suspected condition of bacterial pericarditis related to clinical criteria (chest pain) and imagenological criteria (new pericardial effusion). The focus on pericardiocentesis, highlighting their drainage; specific antibiotic therapy (according to antibiogram) and optimized (sinergized an related to pharmacodinamic).
References
Babua C, Kalyesubula R, Okello E, Kakande B, Sebatta E, Mungoma M, et al. Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study. BMC Nephrol. 2015;16:126. https://doi.org/10.1186/s12882-015-0128-z
Schmidbauer ML, Jones SA, Lim K. Miles RG. Purulent pericarditis: a rare cause for pericardial effusions in a patient with chronic kidney disease. Intern Med J. 2018;48(8):1004-5. https://doi.org/10.1111/imj.13981
Koster N, Narmi A, Anand K. Bacterial pericarditis. Am J Med. 2009; 122(5):e1-2. https://doi.org/10.1016/j.amjmed.2008.11.012
Chahine J, Siddiqui WJ. Pericardial Friction Rub. En: StatPearls [internet]. Treasure Island, Florida, Estados Unidos: StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK542284/
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64. https://doi.org/10.1093/eurheartj/ehv318
Monzon T, Valga F, Mahtani V. Pericarditis purulenta por Salmonella enterica en un paciente con enfermedad renal crónica. Med Clin. 2018;150(9):e27. https://doi.org/10.1016/j.medcli.2017.09.019
Tam WC, Lee WS, Cheng CY. Purulent pericarditis complicating cardiac tamponade in a uremic patient caused by Staphylococcus aureus. J Microbiol Immunol Infect. 2018;51(5):695-6. https://doi.org/10.1016/j.jmii.2017.09.004
Bulut Av?ar C, Aydemir ?, Ta?bakan M, Pullukçu H, Ulusoy S, Kay?kç?o?lu LM, et al. Stenotrophomonas maltophilia pericarditis. Anatol J Cardiol. 2017;18(6):439-40. https://doi.org/10.14744/anatoljcardiol.2017.8024
Murata H, Yoshimoto H, Masuo M, Tokuda H, Kitamura S, Otsuka Y, et al. Fulminant pneumonia due to Aeromonas hydrophila in a man with chronic renal failure and liver cirrhosis. Intern Med. 2001;40(2):118-23. https://doi.org/10.2169/internalmedicine.40.118
Rehman KA, Betancor J, Xu B, Kumar A, Godoy Rivas C, Sato K, et al. Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology. Clin Cardiol. 2017;40(10): 839-46. https://doi.org/10.1002/clc.22770
Dad T, Sarnak MJ. Pericarditis and pericardial effusions in end-stage renal disease. Semin Dial. 2016;29(5):366-73. https://doi.org/10.1111/sdi.12517
Pankuweit S, Risti? AD, Seferovi? PM, Maisch B. Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs. 2005;5(2):103-12. https://doi.org/10.2165/00129784-200505020-00004
Chang SA. Tuberculous and infectious pericarditis. Cardiol Clin. 2017;35(4):615-22. https://doi.org/10.1016/j.ccl.2017.07.013
Pasquau-Liaño J, Sadyrbaeva-Dolgova S, Sequera-Arquellada S, García-Vallecillos C, Hidalgo-Tenorio C. Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program. Rev Esp Quimioter. 2022; 35(supl. 3):102-7. https://doi.org/10.37201/req/s03.22.2022
Blot SI, Pea F, Lipman J. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014;77:3-11. https://doi.org/10.1016/j.addr.2014.07.006
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.